All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Hepatitis B Virus Infection-38564936
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 38564936 A2159G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
I
C
L
View
2 38564936 G1896A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
I
C
L
View
3 38564936 A2189C
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
4 38564936 C2102T
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
5 38564936 G1764A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
6 38564936 A1630G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
7 38564936 A1679G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
8 38564936 A1703G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
9 38564936 A2062C
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
10 38564936 A2120G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
11 38564936 C1627T
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
12 38564936 C1687T
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
13 38564936 C2063A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
14 38564936 C2078G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
15 38564936 C2107A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
16 38564936 C2183A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
17 38564936 C258A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
18 38564936 G1862A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
19 38564936 G2401A
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
20 38564936 T1758C
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
21 38564936 T1765C
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
22 38564936 T2012C
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
23 38564936 T2093G
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
24 38564936 A1762T
BCP;PreC;C
C
Hepatitis B Virus Infection
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.